LBO — METHODIST RICHARDSON MEDICAL CENTER
IRR: 15.7% | MOIC: 2.07x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
15.7%
IRR
2.07x
MOIC
$677.0M
Entry EV
$983.1M
Exit EV
$348.3M
Equity Invested
Sources & Uses
S&UTotal · $677.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $262.9M | 38.8% | |
| Sub Debt | $65.7M | 9.7% | |
| Equity | $348.3M | 51.5% | |
| Enterprise Value | $657.2M | 97.1% | |
| Transaction Fees | $19.7M | 2.9% | |
| Total Uses | $677.0M | 100.0% |
Interpretation
INTAt 2.07x MOIC and 15.7% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $93.6M |
| Exit Ev | $983.1M |
| Net Debt At Exit | $262.0M |
| Equity At Exit | $721.1M |
| Equity Invested | $348.3M |
| Total Value Created | $372.7M |
| Value From Growth | $293.0M |
| Value From Multiple | $32.9M |
| Value From Deleveraging | $66.6M |